Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.

Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, Teoh EJ, Cheng WC, Lord S, Anastasiou D, Haider S, McIntyre A, Goberdhan DCI, Buffa F, Harris AL.

Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12452-12461. doi: 10.1073/pnas.1818521116. Epub 2019 May 31.

2.

Points & Pearls: Emergency department diagnosis and treatment of sexually transmitted diseases

Pfennig-Bass CL, Bridges EP, Gupta N, Nusbaum J.

Emerg Med Pract. 2019 Apr 1;21(Suppl 4):1-2.

PMID:
30943364
3.

Learning to Beat the Shock Clock: A Low-Fidelity Simulation Board Game for Pediatric and Emergency Medicine Residents.

Bridges EP, Foster CE, Park DB, Lehman-Huskamp KL, Mark DW, Tuuri RE.

MedEdPORTAL. 2019 Feb 11;15:10804. doi: 10.15766/mep_2374-8265.10804.

4.

Emergency department diagnosis and treatment of sexually transmitted diseases.

Pfennig-Bass CL, Bridges EP.

Emerg Med Pract. 2019 Apr;21(4):1-32. Epub 2019 Apr 1. Review.

PMID:
30908000
5.

Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.

Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, Whittington HJ, Lake HA, Zervou S, Lygate CA, Kessler BM, Harris AL.

Mol Cancer Res. 2019 Jul;17(7):1531-1544. doi: 10.1158/1541-7786.MCR-18-0315. Epub 2019 Mar 18.

PMID:
30885992
6.

Tunneled Pleural Catheter: Treatment for Recurrent Pleural Effusion.

Miller C, Bridges E, Laxmanan B, Cox-North P, Thompson H.

AACN Adv Crit Care. 2018 Winter;29(4):432-441. doi: 10.4037/aacnacc2018806.

PMID:
30523014
7.

Identifying Patients at Risk for Sepsis.

Bridges E, Greco S.

Crit Care Nurse. 2018 Dec;38(6):72-74. doi: 10.4037/ccn2018245. No abstract available.

PMID:
30504500
8.

Assessing the success of hydrological restoration in two conservation easements within Central Florida ranchland.

Sonnier G, Bohlen PJ, Swain HM, Orzell SL, Bridges EL, Boughton EH.

PLoS One. 2018 Jul 3;13(7):e0199333. doi: 10.1371/journal.pone.0199333. eCollection 2018.

9.

Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research.

Currie TE, Turchin P, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5841-E5842. doi: 10.1073/pnas.1807312115. Epub 2018 Jun 14. No abstract available.

10.

Myasthenic Crisis In Pregnancy.

French DM, Bridges EP, Hoskins MC, Andrews CM, Nelson CH.

Clin Pract Cases Emerg Med. 2017 Oct 3;1(4):291-294. doi: 10.5811/cpcem.2017.5.33404. eCollection 2017 Nov.

11.

Noninvasive Blood Pressure Monitoring and Prediction of Fluid Responsiveness to Passive Leg Raising.

Pickett JD, Bridges E, Kritek PA, Whitney JD.

Am J Crit Care. 2018 May;27(3):228-237. doi: 10.4037/ajcc2018867.

12.

Reducing the Risk for Pressure Injury During Combat Evacuation.

Bridges E, Whitney JD, Burr R, Tolentino E.

Crit Care Nurse. 2018 Apr;38(2):38-45. doi: 10.4037/ccn2018223.

13.

Oral Hypertonic Saline Is Effective in Reversing Acute Mild-to-Moderate Symptomatic Exercise -Associated Hyponatremia.

Bridges E, Altherwi T, Correa JA, Hew-Butler T.

Clin J Sport Med. 2018 Jan 23. doi: 10.1097/JSM.0000000000000573. [Epub ahead of print]

PMID:
29369834
14.

CE: Managing Sepsis and Septic Shock: Current Guidelines and Definitions.

Makic MBF, Bridges E.

Am J Nurs. 2018 Feb;118(2):34-39. doi: 10.1097/01.NAJ.0000530223.33211.f5.

PMID:
29329118
15.

Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.

Turchin P, Currie TE, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E144-E151. doi: 10.1073/pnas.1708800115. Epub 2017 Dec 21.

16.

CE: Assessing Patients During Septic Shock Resuscitation.

Bridges E.

Am J Nurs. 2017 Oct;117(10):34-40. doi: 10.1097/01.NAJ.0000525851.44945.70.

PMID:
28914622
17.

Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.

Dos Santos SN, Sheldon H, Pereira JX, Paluch C, Bridges EM, El-Cheikh MC, Harris AL, Bernardes ES.

Oncotarget. 2017 Jul 25;8(30):49484-49501. doi: 10.18632/oncotarget.17718.

18.

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.

Oon CE, Bridges E, Sheldon H, Sainson RCA, Jubb A, Turley H, Leek R, Buffa F, Harris AL, Li JL.

Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969.

19.

Passive Leg-Raising and Prediction of Fluid Responsiveness: Systematic Review.

Pickett JD, Bridges E, Kritek PA, Whitney JD.

Crit Care Nurse. 2017 Apr;37(2):32-47. doi: 10.4037/ccn2017205. Review.

20.

Research in Review: Advancing Critical Care Practice.

Bridges E, McNeill MM, Munro N.

Am J Crit Care. 2016 Dec;26(1):77-88. Review.

21.

MEF2 transcription factors are key regulators of sprouting angiogenesis.

Sacilotto N, Chouliaras KM, Nikitenko LL, Lu YW, Fritzsche M, Wallace MD, Nornes S, García-Moreno F, Payne S, Bridges E, Liu K, Biggs D, Ratnayaka I, Herbert SP, Molnár Z, Harris AL, Davies B, Bond GL, Bou-Gharios G, Schwarz JJ, De Val S.

Genes Dev. 2016 Oct 15;30(20):2297-2309.

22.

Trends in Research with U.S. Military Service Member Participants: A Population-Specific ClinicalTrials.gov Review.

Cook WA, Doorenbos AZ, Bridges EJ.

Contemp Clin Trials Commun. 2016 Aug 15;3:122-130. Epub 2016 Apr 30.

23.

Eszopiclone and Zolpidem Do Not Affect the Prevalence of the Low Arousal Threshold Phenotype.

Smith PR, Sheikh KL, Costan-Toth C, Forsthoefel D, Bridges E, Andrada TF, Holley AB.

J Clin Sleep Med. 2017 Jan 15;13(1):115-119. doi: 10.5664/jcsm.6402.

24.

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

Harjes U, Bridges E, Gharpure KM, Roxanis I, Sheldon H, Miranda F, Mangala LS, Pradeep S, Lopez-Berestein G, Ahmed A, Fielding B, Sood AK, Harris AL.

Oncogene. 2017 Feb 16;36(7):912-921. doi: 10.1038/onc.2016.256. Epub 2016 Aug 29.

25.

Noninvasive Continuous Hemoglobin Monitoring in Combat Casualties: A Pilot Study.

Bridges E, Hatzfeld JJ.

Shock. 2016 Sep;46(3 Suppl 1):55-60. doi: 10.1097/SHK.0000000000000654.

PMID:
27501120
26.

Synovial Sarcoma in the Foot of a 5-Year-Old ChildA Case Report.

Lepow GM, Grimmer DL, Lemar OV, Bridges EA.

J Am Podiatr Med Assoc. 2016 Jul;106(4):283-8. doi: 10.7547/12-141. Review.

PMID:
27489968
27.

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.

da Motta LL, Ledaki I, Purshouse K, Haider S, De Bastiani MA, Baban D, Morotti M, Steers G, Wigfield S, Bridges E, Li JL, Knapp S, Ebner D, Klamt F, Harris AL, McIntyre A.

Oncogene. 2017 Jan 5;36(1):122-132. doi: 10.1038/onc.2016.184. Epub 2016 Jun 13.

28.

To branch or to expand?

Bridges EM, Harris AL.

Elife. 2016 Jun 6;5. pii: e17079. doi: 10.7554/eLife.17079.

29.

Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth.

McIntyre A, Hulikova A, Ledaki I, Snell C, Singleton D, Steers G, Seden P, Jones D, Bridges E, Wigfield S, Li JL, Russell A, Swietach P, Harris AL.

Cancer Res. 2016 Jul 1;76(13):3744-55. doi: 10.1158/0008-5472.CAN-15-1862. Epub 2016 May 17.

30.

Knowledge of Implantable Cardioverter Defibrillator Purpose and Function Among Nurses in the United States.

Steffes SS, Thompson EA, Bridges EM, Dougherty CM.

J Cardiovasc Nurs. 2017 May/Jun;32(3):304-310. doi: 10.1097/JCN.0000000000000339.

PMID:
27111820
31.

Research in Review: Driving Critical Care Practice Change.

Bridges E, McNeill M, Munro N.

Am J Crit Care. 2016 Jan;25(1):76-84. doi: 10.4037/ajcc2016564. Review.

32.

Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.

Yang J, AlTahan A, Jones DT, Buffa FM, Bridges E, Interiano RB, Qu C, Vogt N, Li JL, Baban D, Ragoussis J, Nicholson R, Davidoff AM, Harris AL.

Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15172-7. doi: 10.1073/pnas.1422015112. Epub 2015 Nov 23.

33.

IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide.

Ramcharan R, Aleksic T, Kamdoum WP, Gao S, Pfister SX, Tanner J, Bridges E, Asher R, Watson AJ, Margison GP, Woodcock M, Repapi E, Li JL, Middleton MR, Macaulay VM.

Oncotarget. 2015 Nov 24;6(37):39877-90. doi: 10.18632/oncotarget.5631.

34.

PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.

Mohlin S, Hamidian A, von Stedingk K, Bridges E, Wigerup C, Bexell D, Påhlman S.

Cancer Res. 2015 Nov 1;75(21):4617-28. doi: 10.1158/0008-5472.CAN-15-0708. Epub 2015 Oct 2.

35.

Research at the Bedside: It Makes A Difference.

Bridges EJ.

Am J Crit Care. 2015 Jul;24(4):283-9. doi: 10.4037/ajcc2015586. Review.

36.

Drug-induced liver injury from initial dose of infliximab.

Cheng FK, Bridges EE, Betteridge JD.

Mil Med. 2015 Jun;180(6):e723-4. doi: 10.7205/MILMED-D-14-00485.

PMID:
26032391
37.

Trauma resuscitation and monitoring: military lessons learned.

Bridges EJ, McNeill MM.

Crit Care Nurs Clin North Am. 2015 Jun;27(2):199-211. doi: 10.1016/j.cnc.2015.02.003. Epub 2015 Mar 20. Review.

PMID:
25981723
38.

Improving outcomes from in-hospital cardiac arrest.

Kupchik N, Bridges E.

Am J Nurs. 2015 May;115(5):51-4. doi: 10.1097/01.NAJ.0000465032.97598.3e. No abstract available.

PMID:
25906228
39.

Assessment of pain in less severely ill and injured aeromedical evacuation patients: a prospective field study.

Bridges E, Dukes S, Serres J.

Mil Med. 2015 Mar;180(3 Suppl):44-9. doi: 10.7205/MILMED-D-14-00407.

PMID:
25747630
40.

Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.

Bridges E, Harris AL.

Cancer Cell. 2015 Jan 12;27(1):7-9. doi: 10.1016/j.ccell.2014.12.009.

41.

Chapter 3 innovations in the en route care of combat casualties.

Hatzfeld JJ, Dukes S, Bridges E.

Annu Rev Nurs Res. 2014;32:41-62. doi: 10.1891/0739-6686.32.41. Review.

PMID:
25222537
42.

Ultrasound-guided diagnosis of occult mandibular osteomyelitis.

Hayden GE, Lybrand KS, Bridges EP, Losek JD, Presley BC.

J Emerg Med. 2014 Nov;47(5):557-60. doi: 10.1016/j.jemermed.2014.06.029. Epub 2014 Sep 8.

PMID:
25214180
43.

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.

Mohd Nafi SN, Generali D, Kramer-Marek G, Gijsen M, Strina C, Cappelletti M, Andreis D, Haider S, Li JL, Bridges E, Capala J, Ioannis R, Harris AL, Kong A.

Oncotarget. 2014 Aug 15;5(15):5934-49.

44.

En route care patient safety: thoughts from the field.

McNeill MM, Pierce P, Dukes S, Bridges EJ.

Mil Med. 2014 Aug;179(8 Suppl):11-8. doi: 10.7205/MILMED-D-13-00522.

PMID:
25102543
45.

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.

Feldinger K, Generali D, Kramer-Marek G, Gijsen M, Ng TB, Wong JH, Strina C, Cappelletti M, Andreis D, Li JL, Bridges E, Turley H, Leek R, Roxanis I, Capala J, Murphy G, Harris AL, Kong A.

Oncotarget. 2014 Aug 30;5(16):6633-46.

46.

Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.

Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL.

J Biol Chem. 2014 Aug 15;289(33):23168-76. doi: 10.1074/jbc.M114.576512. Epub 2014 Jun 17.

47.

Noise in the ICU.

Stafford A, Haverland A, Bridges E.

Am J Nurs. 2014 May;114(5):57-63. doi: 10.1097/01.NAJ.0000446780.99522.90. No abstract available.

PMID:
24759480
48.

Functional hemodynamic indicators: author Elizabeth Bridges responds.

Bridges E.

Am J Nurs. 2013 Oct;113(10):12. No abstract available.

PMID:
24195112
49.

The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity.

Gorsi B, Liu F, Ma X, Chico TJ, v A, Kramer KL, Bridges E, Monteiro R, Harris AL, Patient R, Stringer SE.

Angiogenesis. 2014 Jan;17(1):77-91. doi: 10.1007/s10456-013-9379-0.

PMID:
23959107
50.

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Masiero M, Simões FC, Han HD, Snell C, Peterkin T, Bridges E, Mangala LS, Wu SY, Pradeep S, Li D, Han C, Dalton H, Lopez-Berestein G, Tuynman JB, Mortensen N, Li JL, Patient R, Sood AK, Banham AH, Harris AL, Buffa FM.

Cancer Cell. 2013 Aug 12;24(2):229-41. doi: 10.1016/j.ccr.2013.06.004. Epub 2013 Jul 18.

Supplemental Content

Loading ...
Support Center